Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers

A diagnosis of pancreatic cancer is devastating owing to its poor prognosis, with a 5-year survival rate of only 9%. Currently, most individuals are diagnosed at a late stage when treatment options are limited. Early detection of pancreatic cancer provides the greatest hope for making substantial im...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenner, Barbara J., Go, Vay Liang W., Chari, Suresh T., Goldberg, Ann E., Rothschild, Laura J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647107/
https://www.ncbi.nlm.nih.gov/pubmed/28953187
http://dx.doi.org/10.1097/MPA.0000000000000939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647107/
https://www.ncbi.nlm.nih.gov/pubmed/28953187
http://dx.doi.org/10.1097/MPA.0000000000000939

Ejemplares similares